This federal contract award is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,011.32 and has an Ultimate Completion Date of December 9, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/7/25, 10:06 AM